Alecnib 150 Mg Capsules

Alecnib (Alectinib) 150 Mg Alecnib is a mostly selective, central nervous system-active, oral Capsule use for the treatment of people with non-small cell lung cancer (NSCLC) whose tumour identify as anaplastic lymphoma kinase (ALK)-positive.

Specification/Additional Details

• Packaging Size – 56 Capsules
• Brand – ALECTINIB 150
• Composition – ALECNIB
• Manufacturer – Everest
• Prescription/Non prescription
• Form – Capsule2